LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion

Photo from archive.org

Highlights • A correct patient risk stratification is of paramount importance for the proper management of economic and human resources.• Clinical trials are crucial to assessing immunosuppressant prophylaxis and treatment… Click to show full abstract

Highlights • A correct patient risk stratification is of paramount importance for the proper management of economic and human resources.• Clinical trials are crucial to assessing immunosuppressant prophylaxis and treatment to avoid overuse and treatment shortage.• Controlled studies may highlight a potential preventive role of immunosuppressant in the development of Covid-19 severe forms• Despite the risk of infection in rheumatic and gastroenterological diseases a conclusive link with COV-19 remains questionable

Keywords: inflammatory bowel; handle patients; bowel diseases; rheumatic inflammatory; patients autoimmune; autoimmune rheumatic

Journal Title: Autoimmunity Reviews
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.